Clinical Trials Browser

Camurati-Engelmann Syndrome × Gemcitabine × 90 days × Clear all

NCT02937272 2026-04-03

A Study of LY3200882 in Participants With Solid Tumors

Phase 1 Active not recruiting

Camurati-Engelmann Syndrome